• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含枸橼酸铋雷尼替丁、呋喃唑酮及阿莫西林或四环素的一周治疗方案能有效根除幽门螺杆菌:一项多中心、随机、双盲研究。

One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.

作者信息

Lu H, Zhang D Z, Hu P J, Li Z S, Lu X H, Fang X C, Xiao S D

机构信息

Shanghai Institute of Digestive Disease, Shanghai Second Medical University, Shanghai, China.

出版信息

Aliment Pharmacol Ther. 2001 Dec;15(12):1975-9. doi: 10.1046/j.1365-2036.2001.01122.x.

DOI:10.1046/j.1365-2036.2001.01122.x
PMID:11736729
Abstract

BACKGROUND

The metronidazole resistance of Helicobacter pylori strains has increased rapidly.

AIM

To evaluate the efficacy and safety of new 1-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline.

METHODS

One hundred and twenty patients with H. pylori-positive inactive duodenal ulcer or non-ulcer dyspepsia diagnosed by endoscopy were recruited randomly to receive one of two regimens for 7 days: ranitidine bismuth citrate, 350 mg b.d., furazolidone, 100 mg b.d., and either amoxicillin, 1000 mg b.d. (n=60), or tetracycline, 500 mg b.d. (n=60). H. pylori infection was identified by rapid urease testing and histology. 13C-Urea breath test was performed to evaluate the cure of H. pylori infection at least 4 weeks after completion of triple therapy.

RESULTS

The eradication rates of H. pylori by ranitidine bismuth citrate-furazolidone-amoxicillin and ranitidine bismuth citrate-furazolidone-tetracycline regimens were 82% and 85% (P > 0.05), respectively, by intention-to-treat analysis, and 85% and 91% (P > 0.05), respectively, by per protocol analysis. Adverse effects were mild in both ranitidine bismuth citrate-furazolidone-amoxicillin and ranitidine bismuth citrate-furazolidone-tetracycline groups.

CONCLUSIONS

One-week regimens containing ranitidine bismuth citrate, furazolidone and amoxicillin or tetracycline are well tolerated and effective for the eradication of H. pylori.

摘要

背景

幽门螺杆菌菌株对甲硝唑的耐药性迅速增加。

目的

评估含枸橼酸铋雷尼替丁、呋喃唑酮及阿莫西林或四环素的新型1周治疗方案的疗效和安全性。

方法

招募120例经内镜诊断为幽门螺杆菌阳性的非活动性十二指肠溃疡或非溃疡性消化不良患者,随机接受两种治疗方案之一,疗程7天:枸橼酸铋雷尼替丁,350毫克,每日2次;呋喃唑酮,100毫克,每日2次;阿莫西林,1000毫克,每日2次(n = 60),或四环素,500毫克,每日2次(n = 60)。通过快速尿素酶试验和组织学鉴定幽门螺杆菌感染。在三联疗法完成后至少4周进行13C-尿素呼气试验,以评估幽门螺杆菌感染的根除情况。

结果

按意向性分析,枸橼酸铋雷尼替丁-呋喃唑酮-阿莫西林和枸橼酸铋雷尼替丁-呋喃唑酮-四环素方案的幽门螺杆菌根除率分别为82%和85%(P>0.05);按符合方案分析,分别为85%和91%(P>0.05)。枸橼酸铋雷尼替丁-呋喃唑酮-阿莫西林组和枸橼酸铋雷尼替丁-呋喃唑酮-四环素组的不良反应均较轻。

结论

含枸橼酸铋雷尼替丁、呋喃唑酮及阿莫西林或四环素的1周治疗方案耐受性良好,对根除幽门螺杆菌有效。

相似文献

1
One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.含枸橼酸铋雷尼替丁、呋喃唑酮及阿莫西林或四环素的一周治疗方案能有效根除幽门螺杆菌:一项多中心、随机、双盲研究。
Aliment Pharmacol Ther. 2001 Dec;15(12):1975-9. doi: 10.1046/j.1365-2036.2001.01122.x.
2
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.雷尼替丁枸橼酸铋、阿莫西林和甲硝唑一周三联疗法治疗中国幽门螺杆菌感染
Aliment Pharmacol Ther. 2002 Dec;16(12):2067-72. doi: 10.1046/j.1365-2036.2002.01384.x.
3
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.幽门螺杆菌治疗失败后的七天“挽救”疗法:奥美拉唑、铋剂、四环素和甲硝唑与枸橼酸铋雷尼替丁、四环素和甲硝唑的对比
Aliment Pharmacol Ther. 1999 Oct;13(10):1311-6. doi: 10.1046/j.1365-2036.1999.00615.x.
4
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.雷尼替丁枸橼酸铋联合甲硝唑、阿莫西林和克拉霉素治疗幽门螺杆菌感染的一周疗程:RBC-MACH研究
Aliment Pharmacol Ther. 1999 Aug;13(8):1079-84. doi: 10.1046/j.1365-2036.1999.00580.x.
5
Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days.在使用枸橼酸铋雷尼替丁、甲硝唑和四环素治疗7天或10天后根除幽门螺杆菌感染。
Aliment Pharmacol Ther. 1999 Mar;13(3):323-6. doi: 10.1046/j.1365-2036.1999.00485.x.
6
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.基于枸橼酸铋雷尼替丁的三联疗法作为土耳其患者幽门螺杆菌感染的二线治疗方案
J Gastroenterol Hepatol. 2005 Apr;20(4):637-42. doi: 10.1111/j.1440-1746.2005.03801.x.
7
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.使用枸橼酸铋雷尼替丁/阿莫西林/克拉霉素根除幽门螺杆菌3年后,退伍军人的症状减轻,抗分泌治疗需求减少。
Am J Gastroenterol. 2001 May;96(5):1390-5. doi: 10.1111/j.1572-0241.2001.03771.x.
8
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.三种含枸橼酸铋雷尼替丁的7日幽门螺杆菌根除方案的疗效与安全性
Aliment Pharmacol Ther. 1998 Jun;12(6):533-7. doi: 10.1046/j.1365-2036.1998.00342.x.
9
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.枸橼酸铋雷尼替丁联合两种抗生素治疗幽门螺杆菌感染的1周与2周或4周治疗方案比较
Aliment Pharmacol Ther. 2001 Sep;15(9):1493-7. doi: 10.1046/j.1365-2036.2001.01072.x.
10
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.枸橼酸铋雷尼替丁、克拉霉素和甲硝唑一周三联疗法与枸橼酸铋雷尼替丁和克拉霉素两周双联疗法治疗幽门螺杆菌感染的随机临床试验。
Am J Gastroenterol. 1998 Aug;93(8):1228-31. doi: 10.1111/j.1572-0241.1998.00400.x.

引用本文的文献

1
Efficacy and safety of modified tetracycline dosing in a quadruple therapy for : A retrospective single center study.改良四环素剂量在四联疗法中的疗效和安全性:一项回顾性单中心研究。
World J Gastroenterol. 2023 Jun 14;29(22):3508-3518. doi: 10.3748/wjg.v29.i22.3508.
2
Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.基于呋喃唑酮的幽门螺杆菌感染治疗:汇总数据分析。
Saudi J Gastroenterol. 2012 Jan-Feb;18(1):11-7. doi: 10.4103/1319-3767.91729.
3
Furazolidone-based triple therapy for H pylori gastritis in children.
基于呋喃唑酮的三联疗法治疗儿童幽门螺杆菌胃炎。
World J Gastroenterol. 2006 Sep 14;12(34):5544-9. doi: 10.3748/wjg.v12.i34.5544.
4
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.非溃疡性消化不良患者对幽门螺杆菌根除治疗的反应与消化性溃疡疾病患者不同吗?一项系统评价。
World J Gastroenterol. 2005 May 14;11(18):2726-32. doi: 10.3748/wjg.v11.i18.2726.